<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>PATHOMORPHOLOGICAL AND CLINICAL PECULIARITIES OF  RESPIRATORY DISTRESS SYNDROME IN NEWBORNS BORN TO  MOTHERS INFECTED WITH COVID-19</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Zubtiyev Sardor</mods:namePart><mods:namePart type="family">Uktamovich</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Qorabekova Gulhayo Furqat</mods:namePart><mods:namePart type="family">qizi</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This study systematically investigates the etiopathogenesis, clinical course, and histostructural changes of respiratory distress syndrome (RDS) in neonates born to mothers infected with COVID-19 during pregnancy. Histopathological evaluation revealed alveolar structural disorganization, intra-alveolar fibrinoid exudation, surfactant deficiency, interstitial hemorrhages, and microvascular perfusion defects. These alterations suggest that SARS-CoV-2-mediated placental injury contributes to intrauterine hypoxia and subsequent pulmonary dysfunction. The results provide a foundation for early diagnosis and optimization of neonatal intensive care protocols.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-04-18</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation house</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>